Deutsche Bank analyst George Hill lowered the firm’s price target on Elevance Health to $571 from $581 and keeps a Buy rating on the shares post the Q4 results and segment realignment.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ELV:
- 10 Stocks to Buy Before Their Ex-Dividend Dates Arrive, Week of March 6, 2023
- Elevance Health price target raised to $572 from $555 at JPMorgan
- Managed care stocks pressured after CMS’ preliminary Medicare Advantage rates
- Elevance Health price target raised to $565 from $550 at Loop Capital
- Elevance Health price target raised to $523 from $505 at RBC Capital
